Immunohistochemical analysis of Th1/Th2 cytokine profiles and androgen receptor expression in the pathogenesis of nifedipine-induced gingival overgrowth

Journal of Periodontal Research

Volumn 38, Issue 4, 2003, Pages 422-427

  Huang, W T ^a   Lu, H K ^a   Chou, H H ^a   Kuo, Mark Y P ^b  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Androgen receptor; Gingival overgrowth; Nifedipine; Periodontitis

Indexed keywords

ANDROGEN RECEPTOR; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; NIFEDIPINE; CALCIUM CHANNEL BLOCKING AGENT; INTERLEUKIN DERIVATIVE;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; CELL ACTIVITY; CELL LABELING; CELL NUCLEUS; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONNECTIVE TISSUE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; FEMALE; FIBROBLAST; GINGIVA BLEEDING; GINGIVA HYPERPLASIA; GINGIVAL BIOPSY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; MALE; MEDICAL PARAMETERS; MEDICAL RECORD; PATHOGENESIS; PERIODONTICS; PERIODONTITIS; PERIODONTIUM; PROTEIN DETERMINATION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; T LYMPHOCYTE; TH1 CELL; TH2 CELL; TISSUE SECTION; TOOTH EXTRACTION; TOOTH PLAQUE; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; GINGIVA OVERGROWTH; METABOLISM; MIDDLE AGED;

ADULT; CALCIUM CHANNEL BLOCKERS; CELL NUCLEUS; CONNECTIVE TISSUE; FEMALE; FIBROBLASTS; GINGIVAL OVERGROWTH; HUMANS; IMMUNOHISTOCHEMISTRY; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-13; INTERLEUKIN-2; INTERLEUKIN-4; INTERLEUKINS; MALE; MIDDLE AGED; NIFEDIPINE; PERIODONTAL INDEX; PERIODONTITIS; RECEPTORS, ANDROGEN; TH1 CELLS; TH2 CELLS;

EID: 0141671854     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0765.2003.00672.x     Document Type: Article

References (32)

1. Vittek J, Rapport SC, Gordon GG, Munnangi PR, Southren AL. Concentration of circulating hormones and metabolism of androgens by human gingiva. J Periodontol 1979;50:255-264.
2. Southren AL, Rappaport SC, Gordon GG, Vittek J. Specific 5α-dihydrotestosterone receptors in human gingiva. J Clin Endocrinol Metab 1978;47:1378-1382.
3. Ojanotko A, Nienstedt W, Harri MP. Metabolism of testosterone by human healthy and inflamed gingiva in vitro. Arch Oral Biol 1990;25:481-484.
4. Sooriyamoorthy M, Harvey W, Gower DB. Metabolism of testosterone by human gingival fibroblasts in culture. Biochem Soc Trans 1984;12:1113-1114.
5. Sooriyamoorthy M, Harvey W, Gower DB. Testosterone metabolism by muman gingival fibroblasts in vitro. J Dent Res 1984;63:42.
6. Lucey DR. Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic and inflammatory diseases. Clin Microbiol Rev 1996;9:532.
7. Mosmann TR, Coffman RL. Two types of mouse helper T-cell clone. Immunol Today 1987;8:223.
8. Mosmann TR, Coffman RL. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145-173.
9. Romagnani S. Human Th1 and Th2 subsets: doubt no more. Immunol Today 1991;12:256-261.
10. Rook GA, Hernandez-Pando R, Lightman SL. Hormones peripherally activated prohormones, and regulation of the Th1/ Th2 balance. Immunol Today 1994;15:301-303.
11. Daynes RA, Dudley D, Araneo BA. Regulation of murine lymphokine production in vivo - dehydroepiandrosterone in a natural enhancer of IL-2 synthesis by helper T cells. Eur J Immunol 1990;19:319-322.
12. Araneo BA, Dowell T, Diegel M, Daynes RA. Dihydrotestosterone exerts a depressive influence on the production of interleukin-4 (IL-4), IL-5 and interferon-γ (IFN-γ), but not IL-2, by activated murine T cells. Blood 1991;78:688-699.
13. O'Leary TJ, Drake R, Nylon JE. The plaque control record. J Periodontol 1972;43:48-48.
14. Ingles E, Rossmann JA, Caffesse RG. New clinical index for drug-induced gingival overgrowth. Quintessence Int 1999; 30:467-473.
15. McPhaul MJ, Deslypere JP, Allman DR, Gerard RD. The adenovirus-mediated delivery of a receptor gene permits the assessment of androgen receptor function in genital skin fibroblasts cultures. Stimulation of Gs and inhibition of G (0). J Biol Chem 1993;268:26063-26066.
16. Burstein KL, Cidlowski JA. The down side of glucocorticoid receptor regulation. Mol Cell Endocrinol 1992;83:C1-C8.
17. Sooriyamoorthy M, Gower DB, Eley BM. Androgen metabolism in gingival hyperplasia induced by nifedipine and cyclosporin. J Periodont Res 1990;25:25-30.
18. Sooriyamoorthy M, Harvey W, Gower DB. The use of human gingival fibroblasts in culture for studying the effects of phenytoin on testosterone metabolism. Arch Oral Biol 1988;33:353-359.
19. Sooriyamoorthy M, Gower DB. Hormonal influences on gingival tissue: relationship to periodontal disease. J Clin Periodontol 1989;16:201-208.
20. Soory M, Gower DB. Investigation of androgen metabolism by hyperplastic tissue fibroblasts in relation to phenytoin. Med Sci Res 1990;18:835-837.
21. Harel-Raviv M, Eckler M, Lalani K, Raviv E, Gornitsky M. Nifedipine-induced gingival hyperplasia. A comprehensive review and analysis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995;79:715-722.
22. Suzuki T, Suzuki N, Daynes RA. Dehydroepiandrosterone enhances IL-2 production and cytotoxic function of human T cells. Clin Immunol Immunopathol 1991; 61:202-210.
23. Pilon M, Williams-Miller C, Cox DS. Interleukin-2 levels in gingival crevicular fluid in periodontitis. J Dent Res 1991; 70:550 (Abstract 2270).
24. Fujihashi K, Kono Y, Yamamoto M, et al. Interleukin production by gingival mononuclear cells isolated from adult periodontitis patients. J Dent Res 1991; 70:550 (Abstract 2269).
25. Yamazaki K, Nakajima T, Hara K. Immunohistological analysis of T cell functional subsets in chronic inflammatory periodontal disease. Clin Exp Immunol 1995;99:384-391.
26. Manhart SS, Reinhardt RA, Rayne JB, et al. Gingival cell IL-2 and IL-4 in early-onset periodontitis. J Periodontol 1994; 65:807-813.
27. Seymour et al. Cytokines and prostaglandins in immune homeostasis and tissue destruction in periodontal disease. Periodontol 2000 1997;14:112-143.
28. Ciancio SD. Gingival hyperplasia and diphenylhydantoin: a longitudinal study. J Dent Res 1970;49 (Spec Issue A):65 (Abstract).
29. Nuki I, Cooper SH. The role of inflammation in the pathogenesis of gingival enlargement during the administration of Dph in cats. J Periodont Res 1972;7: 102-110.
30. Fitchie JG, Comer RW, Hanes PH, Reeves GW. The reduction of phenytoin-induced gingival overgrowth in a severely disabled patient: a case report. Compendium 1989;10:314-319.
31. Nishikawa S, Tada H, Hamasaki A, et al. Nifedipine-induced gingival hyperplasia: a clinical and in vitro study. J Periodontol 1991;62:30-35.
32. Thomason JM, Ellis JS, Kelly PJ, Seymour RA. Nifedipine pharmacological variables as risk factors for gingival overgrowth in organ-transplant patients. Clin Oral Invest 1997;1:35-39.